These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [History of the hormonal treatment of climacteric disease symptoms]. Kopera H Wien Med Wochenschr; 1991; 141(15):346-8. PubMed ID: 1949836 [TBL] [Abstract][Full Text] [Related]
44. The menopause and the female larynx, clinical aspects and therapeutic options: a literature review. D'haeseleer E; Depypere H; Claeys S; Van Borsel J; Van Lierde K Maturitas; 2009 Sep; 64(1):27-32. PubMed ID: 19632797 [TBL] [Abstract][Full Text] [Related]
45. [Estrogens and the psyche]. Kopera H Wien Klin Wochenschr; 1984 Jun; 96(12):456-62. PubMed ID: 6475072 [TBL] [Abstract][Full Text] [Related]
46. [Prevention and treatment of hormonal spondylopathy]. German DG; Ketrar' EG Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(4):487-92. PubMed ID: 4002937 [TBL] [Abstract][Full Text] [Related]
47. [Hormonal substitution after menopause]. Weidinger H Dtsch Med Wochenschr; 1993 Sep; 118(38):1386-7. PubMed ID: 8404486 [No Abstract] [Full Text] [Related]
48. Development of erythema nodosum in the course of oestrogen replacement therapy. Yang SG; Han KH; Cho KH; Lee AY Br J Dermatol; 1997 Aug; 137(2):319-20. PubMed ID: 9292099 [No Abstract] [Full Text] [Related]
49. Relapse of Graves' disease after oestrogen therapy for climacteric symptoms. Watanobe H; Kawabe H Clin Endocrinol (Oxf); 1996 Oct; 45(4):505. PubMed ID: 8959093 [No Abstract] [Full Text] [Related]
50. [Not Available]. Rioux JE Can Fam Physician; 1983 Apr; 29():764-9. PubMed ID: 21283452 [TBL] [Abstract][Full Text] [Related]
51. Oestrogen replacement therapy after hysterectomy. Clarke A; Black N; Rowe P BMJ; 1992 Nov; 305(6862):1161. PubMed ID: 1463971 [No Abstract] [Full Text] [Related]
52. Setting up a specialist menopause clinic in Ireland: the initial experience. Milner M; Barry-Kinsella C; Short M; Harrison RF Maturitas; 1993 Jan; 16(1):71-7. PubMed ID: 8429805 [TBL] [Abstract][Full Text] [Related]
53. [Effect of Quinestriol in estrogen deficiency syndromes of the menopause]. Braga A; Pianetti F Minerva Ginecol; 1970 Sep; 22(17):842-52. PubMed ID: 5531799 [No Abstract] [Full Text] [Related]
54. Oral estrusol therapy in the menopause. WEINSTEIN BB; BUERGER CL New Orleans Med Surg J; 1949 Aug; 102(2):66-8. PubMed ID: 18146973 [No Abstract] [Full Text] [Related]
57. Prognostic features of menopausal and postmenopausal applicants for life insurance. Schiefeling M J Insur Med; 1996; 28(1):27-34. PubMed ID: 10172866 [TBL] [Abstract][Full Text] [Related]
58. [Menopause and hormone replacement therapy]. Tóth KS Orv Hetil; 2000 Mar; 141(11):547-56. PubMed ID: 10741167 [TBL] [Abstract][Full Text] [Related]
59. Postmenopausal hormone therapy and the risk of cardiovascular disease. Stramba-Badiale M J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340 [TBL] [Abstract][Full Text] [Related]
60. [Cardiovascular risk and hormone replacement therapy in menopause]. Plu-Bureau G Therapie; 1999; 54(3):375-80. PubMed ID: 10500454 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]